Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders
- 19 September 2008
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 46 (4), 242-248
- https://doi.org/10.1136/jmg.2008.059907
Abstract
Background: Segmental duplications at breakpoints (BP4–BP5) of chromosome 15q13.2q13.3 mediate a recurrent genomic imbalance syndrome associated with mental retardation, epilepsy, and/or electroencephalogram (EEG) abnormalities. Patients: DNA samples from 1445 unrelated patients submitted consecutively for clinical array comparative genomic hybridisation (CGH) testing at Children’s Hospital Boston and DNA samples from 1441 individuals with autism from 751 families in the Autism Genetic Resource Exchange (AGRE) repository. Results: We report the clinical features of five patients with a BP4–BP5 deletion, three with a BP4–BP5 duplication, and two with an overlapping but smaller duplication identified by whole genome high resolution oligonucleotide array CGH. These BP4–BP5 deletion cases exhibit minor dysmorphic features, significant expressive language deficits, and a spectrum of neuropsychiatric impairments that include autism spectrum disorder, attention deficit hyperactivity disorder, anxiety disorder, and mood disorder. Cognitive impairment varied from moderate mental retardation to normal IQ with learning disability. BP4–BP5 covers ∼1.5 Mb (chr15:28.719–30.298 Mb) and includes six reference genes and 1 miRNA gene, while the smaller duplications cover ∼500 kb (chr15:28.902–29.404 Mb) and contain three reference genes and one miRNA gene. The BP4–BP5 deletion and duplication events span CHRNA7, a candidate gene for seizures. However, none of these individuals reported here have epilepsy, although two have an abnormal EEG. Conclusions: The phenotype of chromosome 15q13.2q13.3 BP4–BP5 microdeletion/duplication syndrome may include features of autism spectrum disorder, a variety of neuropsychiatric disorders, and cognitive impairment. Recognition of this broader phenotype has implications for clinical diagnostic testing and efforts to understand the underlying aetiology of this syndrome.Keywords
This publication has 48 references indexed in Scilit:
- Variable phenotype and associations in chromosome 22q11.2 microdeletionAmerican Journal of Medical Genetics Part A, 2006
- Array‐based comparative genomic hybridization analysis of recurrent chromosome 15q rearrangementsAmerican Journal of Medical Genetics Part A, 2005
- Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH)Journal of Medical Genetics, 2005
- 3q29 Microdeletion Syndrome: Clinical and Molecular Characterization of a New SyndromeAmerican Journal of Human Genetics, 2005
- Large genomic duplicons map to sites of instability in the Prader- Willi/Angelman syndrome chromosome region (15q11-q13)Human Molecular Genetics, 1999
- Mosaic normal/15q11-q13 duplication associated with developmental delay but normal phenotype.1999
- Centrotemporal spikes in families with rolandic epilepsyNeurology, 1998
- Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traitsTrends in Genetics, 1998
- Mice Deficient in the α7 Neuronal Nicotinic Acetylcholine Receptor Lack α-Bungarotoxin Binding Sites and Hippocampal Fast Nicotinic CurrentsJournal of Neuroscience, 1997
- Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15qHuman Molecular Genetics, 1997